Paul Harnett - Dissemin

All papers authored by Paul Harnett

This paper is made freely available by the publisher.

2022 Candice Donnelly

, Anna Janssen, Shalini Vinod

, Emily Stone, Paul Harnett

, Tim Shaw

A Systematic Review of Electronic Medical Record Driven Quality Measurement and Feedback Systems

Download from doi.org

Nicola S. Meagher, Robyn L. Ward, Rebekka Wiedenhoefer, Anna H. Wu, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon, Chi Nam Ignatius Pang, Derek S. Chiu

, Joellen M. Schildkraut, Michael S. Anglesio, Kylie-Ann Mallitt, Kara L. Cushing Haugen, Jennifer A. Doherty, Holly R. Harris and 102 other authors

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Download from aacrjournals.org

Dale W. Garsed

, Ahwan Pandey

, Sian Fereday

, Catherine J. Kennedy

, Kazuaki Takahashi, Kathryn Alsop, Phineas T. Hamilton, Joy Hendley, Yoke-Eng Chiew, Nadia Traficante, Pamela Provan

, Dinuka Ariyaratne

, George Au-Yeung, Nicholas W. Bateman

, Leanne Bowes and 25 other authors

The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

Download from www.nature.com

Karolin Heinze

, Andreas du Bois, Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu, Samuel Cy Leung, Eun Young Kang, Nicola S. Meagher, Catherine J. Kennedy, Jessica Boros, Friedrich Kommoss, Hans‐Walter Vollert, Florian Heitz and 68 other authors

Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8 ⁺ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas

Download from onlinelibrary.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

Tania Moujaber, Rosemary L. Balleine, Bo Gao, Ida Madsen, Paul R. Harnett

, Anna DeFazio

New therapeutic opportunities for women with low-grade serous ovarian cancer

Upload

2021 Phuong Dinh, J. Dinny Graham, Elisabeth N. Elder, Masrura Kabir, Tram B. Doan, James French, Farid Meybodi, Rina Hui, Nicholas R. Wilcken, Paul R. Harnett

, Jeremy Hsu, Kirsty E. Stuart, Tim Wang, Verity Ahern, Meagan Brennan and 6 other authors

Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing

Upload

Yiren Liu, Lynleigh Evans, Terence Kwan, James Callister, Simon Poon, Karen Byth, Paul Harnett

Developing a maturity model for cancer multidisciplinary teams

Upload

Eun Young Kang, Joshua Millstein, Gordana Popovic, Nicola S. Meagher, Adelyn Bolithon, Aline Talhouk, Derek S. Chiu, Michael S. Anglesio, Betty Leung, Katrina Tang, Neil Lambie, Marina Pavanello, Annalyn Da-Anoy, Diether Lambrechts

, Liselore Loverix and 99 other authors

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

Download from link.springer.com

Jermaine I. Coward

, Minal A. Barve, Ganessan Kichenadasse

, Kathleen N. Moore, Paul R. Harnett

, Daniel Berg, James S. Garner, Don S. Dizon

Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results

Download from doi.org

Lynleigh Evans

, Yiren Liu, Brendan Donovan, Terence Kwan, Karen Byth, Paul Harnett

Improving Cancer MDT performance in Western Sydney – three years’ experience

Download from link.springer.com

2020 Anna Janssen

, Candice Donnelly

, Judy Kay

, Peter Thiem

, Aldo Saavedra

, Nirmala Pathmanathan

, Elisabeth Elder

, Phuong Dinh

, Masrura Kabir

, Kirsten Jackson

, Paul Harnett

, Tim Shaw

Developing an Intranet-Based Lymphedema Dashboard for Breast Cancer Multidisciplinary Teams: Design Research Study

Download from doi.org

2019 Michael Friedlander, Tarek Meniawy, Ben Markman, Linda Mileshkin, Paul Harnett

, Michael Millward, Joanne Lundy, Alison Freimund, Christie Norris, Song Mu, John Wu, Virginia Paton, Bo Gao

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Upload

Nicola S. Meagher

, Linyuan Wang, Peter F. Rambau, Maria P. Intermaggio, David G. Huntsman, Lynne R. Wilkens, Mona A. El-Bahrawy, Roberta B. Ness, Kunle Odunsi, Helen Steed, Esther Herpel, Michael S. Anglesio, Bonnie Zhang, Neil Lambie, Anthony J. Swerdlow and 67 other authors

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

Download from www.nature.com

Lynleigh Evans, Brendan Donovan, Yiren Liu, Tim Shaw, Paul Harnett

A tool to improve the performance of multidisciplinary teams in cancer care

Upload

Tim Shaw, Anna Janssen, Roslyn Crampton, Fenton O'Leary, Philip Hoyle, Aaron Jones, Amith Shetty, Naren Gunja, Angus G. Ritchie, Heiko Spallek, Annette Solman, Judy Kay, Meredith Ab Makeham, Paul Harnett

Attitudes of health professionals to using routinely collected clinical data for performance feedback and personalised professional development

Download from api.wiley.com

2018 Tania Moujaber, Catherine J. Kennedy, Catherine Saunders, Gerard V. Wain, P. R. Harnett, G. Chenevix-Trench, A. Green, P. Webb, Russell Hogg, D. Gertig, S. Moore, K. Harrap, T. Sadkowsky, N. Pandeya, Sivatharsny Srirangan and 157 other authors

BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition

Download from doi.org